Harrison HealthPartners Hematology and Oncology-Bremerton is a clinical research site located in Bremerton, Washington, United States 98310.
Crixeo Health Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.
Harrison HealthPartners Hematology and Oncology-Bremerton has participated in 124 clinical trials with 34 currently active.
Therapeutic areas: Plasma Cell Myeloma, Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Colorectal Adenocarcinoma.
Sponsors: ECOG-ACRIN Cancer Research Group, SWOG Cancer Research Network, Alliance for Clinical Trials in Oncology.
Trust Score: 88/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Harrison HealthPartners Hematology and Oncology-Bremerton has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Harrison HealthPartners Hematology and Oncology-Bremerton has 124 clinical trials on record, with 34 currently active. Their work covers Plasma Cell Myeloma, Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Colorectal Adenocarcinoma.
Yes — Harrison HealthPartners Hematology and Oncology-Bremerton holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.